Cargando…
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates DSS-induced intestinal colitis by improving intestinal mucosal barrier function
BACKGROUND AND AIMS: Cholinergic output, which could modulate innate immune responses through stimulation of α7 nicotinic acetylcholine receptor (α7nAChR), might be a target to minimize tissue damage in autoimmune disease. GTS-21, a selective α7nAChR agonist, has previously demonstrated to inhibit s...
Autores principales: | Ye, Ziping, Zhu, Yunjuan, Tang, Nana, Zhao, Xiaojing, Jiang, Jingyue, Ma, Jingjing, Zhang, Hongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164421/ https://www.ncbi.nlm.nih.gov/pubmed/35659178 http://dx.doi.org/10.1186/s10020-022-00485-6 |
Ejemplares similares
-
The selective α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced inflammation and lung injury
por: Kox, M, et al.
Publicado: (2009) -
Effects of splenectomy and GTS-21, a selective α7 nicotinic acetylcholine receptor agonist, on the development of septic ileus in mice
por: Nullens, S, et al.
Publicado: (2014) -
Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
por: Park, Jung-Eun, et al.
Publicado: (2022) -
GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Lepr(db/db) mice
por: Meng, Qinghe, et al.
Publicado: (2022) -
GTS-21 has cell-specific anti-inflammatory effects independent of α7 nicotinic acetylcholine receptors
por: Garg, Brijesh K., et al.
Publicado: (2019)